227 related articles for article (PubMed ID: 27613418)
1. PCAF-mediated acetylation of transcriptional factor HOXB9 suppresses lung adenocarcinoma progression by targeting oncogenic protein JMJD6.
Wan J; Xu W; Zhan J; Ma J; Li X; Xie Y; Wang J; Zhu WG; Luo J; Zhang H
Nucleic Acids Res; 2016 Dec; 44(22):10662-10675. PubMed ID: 27613418
[TBL] [Abstract][Full Text] [Related]
2. PCAF-primed EZH2 acetylation regulates its stability and promotes lung adenocarcinoma progression.
Wan J; Zhan J; Li S; Ma J; Xu W; Liu C; Xue X; Xie Y; Fang W; Chin YE; Zhang H
Nucleic Acids Res; 2015 Apr; 43(7):3591-604. PubMed ID: 25800736
[TBL] [Abstract][Full Text] [Related]
3. Acetylated HOXB9 at lysine 27 is of differential diagnostic value in patients with pancreatic ductal adenocarcinoma.
Sun X; Song J; Zhang J; Zhan J; Fang W; Zhang H
Front Med; 2020 Feb; 14(1):91-100. PubMed ID: 31372881
[TBL] [Abstract][Full Text] [Related]
4. HOXB9 acetylation at K27 is responsible for its suppression of colon cancer progression.
Song J; Wang T; Xu W; Wang P; Wan J; Wang Y; Zhan J; Zhang H
Cancer Lett; 2018 Jul; 426():63-72. PubMed ID: 29654889
[TBL] [Abstract][Full Text] [Related]
5. High expression of transcriptional factor HoxB9 predicts poor prognosis in patients with lung adenocarcinoma.
Zhan J; Wang P; Niu M; Wang Y; Zhu X; Guo Y; Zhang H
Histopathology; 2015 Jun; 66(7):955-65. PubMed ID: 25324169
[TBL] [Abstract][Full Text] [Related]
6. High expression of JMJD6 predicts unfavorable survival in lung adenocarcinoma.
Zhang J; Ni SS; Zhao WL; Dong XC; Wang JL
Tumour Biol; 2013 Aug; 34(4):2397-401. PubMed ID: 23595221
[TBL] [Abstract][Full Text] [Related]
7. Elevated HOXB9 expression promotes differentiation and predicts a favourable outcome in colon adenocarcinoma patients.
Zhan J; Niu M; Wang P; Zhu X; Li S; Song J; He H; Wang Y; Xue L; Fang W; Zhang H
Br J Cancer; 2014 Aug; 111(5):883-93. PubMed ID: 25025961
[TBL] [Abstract][Full Text] [Related]
8. HOXB9 promotes endometrial cancer progression by targeting E2F3.
Wan J; Liu H; Feng Q; Liu J; Ming L
Cell Death Dis; 2018 May; 9(5):509. PubMed ID: 29724991
[TBL] [Abstract][Full Text] [Related]
9. GalNAc-T14 promotes metastasis through Wnt dependent HOXB9 expression in lung adenocarcinoma.
Kwon OS; Oh E; Park JR; Lee JS; Bae GY; Koo JH; Kim H; Choi YL; Choi YS; Kim J; Cha HJ
Oncotarget; 2015 Dec; 6(39):41916-28. PubMed ID: 26544896
[TBL] [Abstract][Full Text] [Related]
10. GATA3 acetylation at K119 by CBP inhibits cell migration and invasion in lung adenocarcinoma.
Li X; Jin J; Yang S; Xu W; Meng X; Deng H; Zhan J; Gao S; Zhang H
Biochem Biophys Res Commun; 2018 Mar; 497(2):633-638. PubMed ID: 29453984
[TBL] [Abstract][Full Text] [Related]
11. PCAF-mediated acetylation of Lin28B increases let-7 biogenesis in lung adenocarcinoma H1299 cells.
Qu TT; Chen F; Wang J; Zhang YJ; Cheng MB; Sun WZ; Shen YF; Zhang Y
BMC Cancer; 2018 Jan; 18(1):27. PubMed ID: 29301498
[TBL] [Abstract][Full Text] [Related]
12. Snail acetylation by histone acetyltransferase p300 in lung cancer.
Chang R; Zhang Y; Zhang P; Zhou Q
Thorac Cancer; 2017 May; 8(3):131-137. PubMed ID: 28296173
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of NMI promotes tumor growth and predicts poor prognosis in human lung adenocarcinomas.
Wang J; Zou K; Feng X; Chen M; Li C; Tang R; Xuan Y; Luo M; Chen W; Qiu H; Qin G; Li Y; Zhang C; Xiao B; Kang L; Kang T; Huang W; Yu X; Wu X; Deng W
Mol Cancer; 2017 Oct; 16(1):158. PubMed ID: 29025423
[TBL] [Abstract][Full Text] [Related]
14. HOXB9 enhances the ability of lung cancer cells to penetrate the blood-brain barrier.
Zheng H; Li C; Li Z; Zhu K; Bao H; Xiong J; Liang P
Aging (Albany NY); 2020 Dec; 13(4):4999-5019. PubMed ID: 33411683
[TBL] [Abstract][Full Text] [Related]
15. P300/CBP-associated factor (PCAF)-mediated acetylation of Fascin at lysine 471 inhibits its actin-bundling activity and tumor metastasis in esophageal cancer.
Cheng YW; Zeng FM; Li DJ; Wang SH; He JZ; Guo ZC; Nie PJ; Wu ZY; Shi WQ; Wen B; Xu XE; Liao LD; Li ZM; Wu JY; Zhan J; Zhang HQ; Chang ZJ; Zhang K; Xu LY; Li EM
Cancer Commun (Lond); 2021 Dec; 41(12):1398-1416. PubMed ID: 34555274
[TBL] [Abstract][Full Text] [Related]
16. Lysyl 5-hydroxylation, a novel histone modification, by Jumonji domain containing 6 (JMJD6).
Unoki M; Masuda A; Dohmae N; Arita K; Yoshimatsu M; Iwai Y; Fukui Y; Ueda K; Hamamoto R; Shirakawa M; Sasaki H; Nakamura Y
J Biol Chem; 2013 Mar; 288(9):6053-62. PubMed ID: 23303181
[TBL] [Abstract][Full Text] [Related]
17. JMJD6 promotes melanoma carcinogenesis through regulation of the alternative splicing of PAK1, a key MAPK signaling component.
Liu X; Si W; Liu X; He L; Ren J; Yang Z; Yang J; Li W; Liu S; Pei F; Yang X; Sun L
Mol Cancer; 2017 Nov; 16(1):175. PubMed ID: 29187213
[TBL] [Abstract][Full Text] [Related]
18. The long non-coding RNA HNF1A-AS1 regulates proliferation and metastasis in lung adenocarcinoma.
Wu Y; Liu H; Shi X; Yao Y; Yang W; Song Y
Oncotarget; 2015 Apr; 6(11):9160-72. PubMed ID: 25863539
[TBL] [Abstract][Full Text] [Related]
19. Acetylation of FOXM1 is essential for its transactivation and tumor growth stimulation.
Lv C; Zhao G; Sun X; Wang P; Xie N; Luo J; Tong T
Oncotarget; 2016 Sep; 7(37):60366-60382. PubMed ID: 27542221
[TBL] [Abstract][Full Text] [Related]
20. BRCA1 function in the intra-S checkpoint is activated by acetylation via a pCAF/SIRT1 axis.
Lahusen TJ; Kim SJ; Miao K; Huang Z; Xu X; Deng CX
Oncogene; 2018 Apr; 37(17):2343-2350. PubMed ID: 29440709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
